Cellular Performance Institute

What Cellular Performance Institute does

Cellular Performance Institute (CPI) is a private regenerative medicine hospital located in Tijuana, Baja California, Mexico, operating within the Translational Advanced Medical (TAM) Center approximately 20 minutes from the San Diego border. Founded in 2015 and licensed by COFEPRIS (Mexico's FDA), CPI specializes in stem cell therapy with a core product of Expanded Hypoxic Mesenchymal Stem Cells derived from umbilical cord tissue and manufactured in-house at an ISO-7 certified cGMP laboratory. Treatment categories include orthopedic and sports injuries, disc regeneration, autoimmune diseases, neurological degeneration, chronic pain relief, anti-aging, and biohacking, bundled into a 5-Day Protocol that includes hotel accommodation at the Hyatt Tijuana, ground transportation with border-crossing handling, and adjunctive NAD+ IV, hyperbaric oxygen, PEMF therapy, and IV vitamin C.

CPI generates revenue through professional services fees for inpatient treatment packages plus a recurring aftercare telemedicine subscription, operating on a quote-based direct-to-consumer model targeting primarily US patients. The go-to-market relies heavily on celebrity and athlete endorsements—most prominently the Official UFC Stem Cell Therapy Provider designation (2024), 24 Joe Rogan podcast mentions, and testimonials from UFC fighters, WWE Hall of Famers, and BJJ champions—and patient testimonials across athlete, chronic pain, autoimmune, neurological, and longevity segments. Operational scale includes 51-100 employees, more than 4,000 direct intradiscal injections performed (claimed as the highest worldwide), and published clinical outcomes including 78.1% patient-reported improvement at 10-year follow-up and 85% MRI-confirmed disc bulge reduction.

Name

Cellular Performance Institute

Legal name

Cellular Performance Institute

Website

https://cellularperformanceinstitute.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

51–100 employees

Short description

Cellular Performance Institute is a private, COFEPRIS-licensed regenerative medicine hospital in Tijuana, Mexico, that provides hypoxic mesenchymal stem cell therapy and adjunctive treatments (NAD+, HBOT, PEMF) primarily to US patients traveling for sports injuries, disc degeneration, autoimmune conditions, and anti-aging indications.

Ownership category

akta.pro rank

Product category

Regenerative Medicine

NAICS

Other Ambulatory Health Care Services (6219), Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), Ambulatory Health Care Services (621)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-General Medical & Surgical Hospitals, Nec (8062), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring) (HLAAABAJ)

akta.pro secondary industries

Stem Cell Therapies (MSC/iPSC/HSC-derived) (HLAAABAE), Stem Cell–Based Regenerative Therapies (HLAAAGAA)

Keywords

• Stem cell therapy
• Regenerative medicine
• Cellular therapy
• Orthopedic injury treatment
• Disc regeneration therapy

Headquarters

HQ city

Baja California

HQ country

Mexico

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Medical Treatment Services: CPI generates revenue through providing stem cell therapy treatments and related medical services at their licensed hospital facility in Tijuana. Treatments include hypoxic mesenchymal stem cell therapy, NAD+ IV therapy, hyperbaric oxygen therapy, PEMF therapy, and other regenerative treatments. The 5-Day Protocol package includes accommodation, transportation, blood work, imaging, and personalized treatment protocols.
2. Aftercare Telemedicine: Post-treatment telemedicine program providing remote follow-up care, review of post-treatment exams and MRIs, and ongoing patient support during recovery.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Core offering

Cellular Performance Institute operates a licensed regenerative medicine hospital in Tijuana, Mexico, providing proprietary hypoxic mesenchymal stem cell therapy combined with NAD+ IV therapy, hyperbaric oxygen therapy, PEMF therapy, and IV Vitamin C through a comprehensive 5-Day Protocol package. Treatments target orthopedic injuries, degenerative disc disease, autoimmune conditions, neurological disorders, chronic pain, and anti-aging, with all stem cells manufactured in-house at an ISO-7 certified cGMP laboratory. The service includes hotel accommodation, ground transportation with border crossing handling, diagnostics, and post-treatment telemedicine follow-up.

Product overview

Cellular Performance Institute (CPI) operates as a licensed hospital within the Translational Advanced Medical (TAM) Center in Tijuana, Mexico, offering a portfolio of regenerative medicine treatments anchored by its proprietary Expanded Hypoxic Mesenchymal Stem Cells. The core product is the 5-Day Protocol—a comprehensive inpatient treatment package that bundles stem cell therapy with synergistic supporting treatments including NAD+ IV Therapy, Hyperbaric Oxygen Therapy, Pulsed Electro-Magnetic Field Therapy, and IV Vitamin C, along with accommodation, transportation, and diagnostic imaging. CPI specializes in treatment categories spanning Anti-Aging & Rejuvenation, Sports & Orthopedic Injuries, Autoimmune Diseases, Neurological Degeneration, Disc Regeneration (with over 4,000 direct intradiscal injections performed), Chronic Pain Relief, and Biohacking. All cellular products are manufactured in-house at CPI's ISO-7 certified cGMP laboratory using a characterized master cell bank of hypoxic umbilical cord-derived mesenchymal stem cells.

Differentiator

Problem solved

Functional benefit

Products and services

• 5-Day Protocol A comprehensive inpatient treatment package including hotel accommodation at Hyatt Hotel in Tijuana, all ground transportation with border crossing handling, complete blood work panel, X-rays, hyperbaric oxygen therapy, IV NAD+, Myers Vitamin IV, PEMF therapy, and personalized cell therapy protocol, designed for patients traveling from the US and internationally for regenerative medicine treatment.
• Disc Regeneration Treatment Specialized treatment for degenerative disc disease involving direct intradiscal injection of hypoxic stem cells to repair damaged disc tissue, reduce inflammation, and reverse disc degeneration, with over 4,000 procedures performed by CPI (more than any other facility worldwide) and backed by 10-year clinical follow-up data showing 78.1% patient-reported improvement.
• Direct Intradiscal Stem Cell Injection Fluoroscopy-guided injection of hypoxic mesenchymal stem cells directly into the nucleus pulposus of damaged discs for treatment of degenerative disc disease, herniated discs, bulging discs, and sciatica, with over 4,000 procedures performed by CPI (more than any other facility worldwide).
• Anti-Aging & Rejuvenation Treatment Comprehensive treatment protocol utilizing hypoxic mesenchymal stem cells combined with synergistic therapies (NAD+, HBO, PEMF) to reduce inflammation, repair damaged tissue, and address telomere shortening associated with aging, targeted at individuals seeking cellular-level rejuvenation.
• Sports & Orthopedic Injuries Treatment Regenerative therapy for sports injuries including tendinopathy, damaged knees, injured shoulders, herniated discs, torn ligaments, torn meniscus, and torn muscles, using stem cells to regrow tissue and support natural healing processes, primarily for professional athletes and active individuals.
• Autoimmune Disease Treatment Stem cell therapy protocol using hypoxic mesenchymal stem cells to modulate overactive or underperforming immune systems, producing anti-inflammatory responses and promoting T-regulatory cell production, targeted at patients with Rheumatoid Arthritis, Lupus, Psoriasis, and other autoimmune conditions.
• Neurological Degeneration Treatment Regenerative therapy for neurological conditions including Alzheimer's Disease, Dementia, Parkinson's Disease, stroke, and spinal cord injuries using intrathecal stem cell delivery to reach the nervous system directly.
• Chronic Pain Relief Treatment Non-opioid treatment approach using mesenchymal stem cells to regenerate damaged tissue and address chronic pain from arthritis, connective tissue injuries, degenerative disc diseases, joint pain, and neuropathy.
• Biohacking / Bio Longevity Treatment Life-extending treatment program combining cutting-edge scientific team expertise with medical staff to deliver advanced therapies for body enhancement and optimization, including genetic testing, whole exome sequencing, and custom peptide manufacturing for biohacking and longevity.

Quantifiable outcome

• 78.1% patient-reported improvement (SANE score) at 10 years follow-up with zero adverse events
• +4 more outcomes

Named customers8 records

Segments6 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered flagship, core and minor.

• Ultimate Fighting Championship (UFC)flagshipGTM or Marketing Partner · 1 January 2024In 2024, CPI signed a deal to become the Official Stem Cell Therapy Provider of the UFC. This partnership provides high-profile visibility and credibility through association with elite combat sports. CPI has treated numerous UFC athletes seeking accelerated recovery and injury repair.
• Translational Advanced Medical (TAM) CentercoreStrategic or Co-development PartnerCPI operates within the TAM Center ecosystem, providing access to fully licensed hospital facility, advanced diagnostics (Next-Generation Sequencing, Optical Genome Mapping, Proteomics, digital pathology), and collaboration with esteemed scientists and doctors in translational medicine.
• Joe RogancoreGTM or Marketing PartnerJoe Rogan has recommended CPI on his podcast 24 times, featuring patients who achieved excellent results. His repeated unsolicited endorsement provides significant credibility and patient acquisition through one of the most influential voices in health and wellness.
• Hyatt Hotel TijuanaminorOthersCPI's 5-Day Protocol includes hotel accommodation at the Hyatt Hotel in Tijuana's restaurant district for patients during treatment visits.

Scale indicators7 records

Recent moves3 records

Expansion highlights6 records

Direct peers

• BioXcellerator: BioXcellerator is a stem cell therapy clinic in Medellin, Colombia with a near-identical model: high-volume MSC treatments, direct-to-consumer US patient acquisition, celebrity and athlete endorsements, and bundled medical-tourism packages. It is the closest direct competitor to CPI in the cross-border stem cell tourism category.
• Swiss Medica: Swiss Medica operates stem cell clinics in Serbia, Russia, and Switzerland offering MSC-based therapies for orthopedic, neurological, and anti-aging indications. It is a comparable cross-border stem cell tourism provider targeting US and European patients.
• Regenexx: Regenexx is the largest US-based orthopedic stem cell and platelet-rich plasma network, with published outcomes and an emphasis on interventional orthopedics. It directly competes with CPI for US patients seeking non-surgical alternatives for joint, spine, and sports injuries.
• Celltex Therapeutics: Celltex Therapeutics is a Mexico-based stem cell banking and therapy company that stores autologous MSCs and provides treatments for orthopedic and autoimmune indications. It is a direct peer in the cross-border US-Mexico regenerative medicine space.
• GIOSTAR: GIOSTAR operates a global network of stem cell treatment centers in Mexico and other countries, offering autologous and allogeneic MSC therapies across orthopedic, autoimmune, and chronic conditions. It competes directly with CPI in the Mexico-based US-patient medical tourism market.
• Stem Cell Institute (Dr. Neil Riordan): Stem Cell Institute in Panama is a long-established stem cell therapy clinic treating orthopedic, neurological, autoimmune, and degenerative conditions with umbilical cord-derived MSCs. It is one of the most recognized cross-border stem cell destinations and a direct peer to CPI's offering.

Emerging players

• Kimera Labs: Kimera Labs is a US-based MSC and exosome manufacturer supplying clinics and researchers with allogeneic MSC products. It is comparable to CPI on the cell manufacturing side, particularly as CPI claims to be the world's largest MSC producer and could sell surplus capacity to peers like Kimera.
• Centeno-Schultz Clinic: Centeno-Schultz Clinic is the founding clinic of the Regenexx network in Broomfield, Colorado, with deep published research on image-guided intradiscal and orthopedic stem cell injections. It overlaps with CPI's intradiscal injection leadership and orthopedic indications, but operates domestically under US regulations.

Regional players

• Beike Biotechnology: Beike Biotechnology is a China-based provider of umbilical cord-derived MSC therapies used in clinical research and medical tourism across Asia. It is a comparable MSC therapy platform but operates primarily in Asia rather than competing head-to-head with CPI in the US-Mexico corridor.

Broad incumbents

• Celularity: Celularity is a publicly traded cell therapy company developing placenta-derived and MSC-based allogeneic therapies across oncology, autoimmune, and degenerative indications. It is a broad incumbent in regenerative medicine with overlapping MSC technology but operates in drug development rather than direct patient services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/CPIStemCells
• LinkedInlinkedin.com/company/cellularperformanceinstitute

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cellular Performance Institute